Published in Carcinogenesis on June 24, 2010
New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res (2010) 1.73
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. Cancer Epidemiol Biomarkers Prev (2011) 1.28
Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. Am J Epidemiol (2012) 1.28
The link between benign prostatic hyperplasia and prostate cancer. Nat Rev Urol (2012) 0.98
A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res (2013) 0.93
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial. Prostate (2015) 0.91
Identification of genetic risk associated with prostate cancer using ancestry informative markers. Prostate Cancer Prostatic Dis (2012) 0.84
Pathologic effects of RNase-L dysregulation in immunity and proliferative control. Front Biosci (Schol Ed) (2012) 0.83
Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study. Prostate (2011) 0.82
Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis. Sci Rep (2015) 0.80
Detection of infectious organisms in archival prostate cancer tissues. BMC Cancer (2014) 0.79
RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response. J Biol Chem (2014) 0.79
Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. Int J Cancer (2014) 0.76
Gene panel model predictive of outcome in patients with prostate cancer. OMICS (2013) 0.76
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet (2012) 0.76
Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer. Iran Red Crescent Med J (2015) 0.75
Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women. Cancer Epidemiol Biomarkers Prev (2015) 0.75
The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients. Springerplus (2013) 0.75
Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses. AIDS Res Hum Retroviruses (2012) 0.75
Genetic variation across C-reactive protein and risk of prostate cancer. Prostate (2014) 0.75
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Retracted Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog (2006) 10.08
Inflammation in prostate carcinogenesis. Nat Rev Cancer (2007) 9.08
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet (2009) 5.06
C-reactive protein and the risk of incident colorectal cancer. JAMA (2004) 4.94
Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66
SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res (2006) 4.63
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J (1997) 4.53
Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol (2008) 4.25
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet (2002) 3.87
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection. Infect Genet Evol (2008) 3.39
C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med (2005) 2.79
Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis (2004) 2.33
A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet (2002) 2.24
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol (1999) 2.00
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial. Cancer (2008) 1.92
RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate (2007) 1.74
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer. BJU Int (2005) 1.69
Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat (2008) 1.60
Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate (2009) 1.45
A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev (2007) 1.42
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev (2005) 1.37
HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2004) 1.35
Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer (2009) 1.29
Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer (2003) 1.19
RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis. Clin Cancer Res (2006) 1.16
C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes Control (2009) 1.13
Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clin Cancer Res (2007) 1.11
Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer Epidemiol Biomarkers Prev (2010) 0.98
RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. Prostate (2008) 0.93
Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes. Cancer Epidemiol Biomarkers Prev (2009) 0.93
Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate (2008) 0.91
Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. Prostate (2006) 0.90
DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland. Urol Int (2007) 0.87
No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk. Prostate (2008) 0.80
Population structure and eigenanalysis. PLoS Genet (2006) 37.21
Integrating common and rare genetic variation in diverse human populations. Nature (2010) 32.30
The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28
Gene expression correlates of clinical prostate cancer behavior. Cancer Cell (2002) 16.27
Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med (2004) 13.57
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 13.30
High-throughput oncogene mutation profiling in human cancer. Nat Genet (2007) 12.68
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med (2009) 10.54
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
Large-scale sequence analysis of avian influenza isolates. Science (2006) 9.87
Reconstructing Indian population history. Nature (2009) 9.28
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science (2008) 9.25
A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24
Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet (2007) 8.74
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One (2008) 7.16
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell (2009) 7.09
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature (2011) 6.39
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut (2008) 6.26
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24
A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature (2002) 6.10
Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet (2011) 6.06
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature (2008) 6.04
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn (2005) 6.00
Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Profiling critical cancer gene mutations in clinical tumor samples. PLoS One (2009) 5.63
Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60
Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med (2014) 5.37
CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods (2011) 5.34
Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Physical activity and weight gain prevention. JAMA (2010) 5.27
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25
Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature (2011) 5.20
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med (2010) 5.05
A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science (2012) 4.92
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet (2006) 4.78
ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst (2009) 4.72
Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72
Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68
Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol (2014) 4.67
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48
Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell (2012) 4.41
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med (2011) 4.37
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet (2009) 4.35
Benzodiazepine use and risk of dementia: prospective population based study. BMJ (2012) 4.32
Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21
Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal (2010) 4.15
Exome sequencing and the genetic basis of complex traits. Nat Genet (2012) 4.11
Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA (2004) 4.04
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn (2006) 3.98
Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96
Association of nut consumption with total and cause-specific mortality. N Engl J Med (2013) 3.94